HBSP (USA)
-
Corrections Corp. of America
Riedl, Edward J.Case HBS-107071-EThis case illustrates a comprehensive valuation of a publicly-traded firm specializing in building and managing prisons. Students must assess the firm's strategy and risks, evaluate key financial reports, derive forecasts of future performance, and use these forecasts to value the firm.Starting at €8.20
-
Corrections Corporation of America, Teaching Note
Riedl, Edward J.Teaching Note HBS-109012-ETeaching Note for [107071].Starting at €0.00
-
Restaurant Valuation: O'Charley's and AFC
Riedl, Edward J.; Everett, JennyCase HBS-111081-EAccounting and ControlThis case is a comparative analysis of the strategy, accounting, performance, and valuation for two restaurant chains alternatively having a company-owned versus franchising strategy. It requires students to identify these two different strategies, and the related impact on the financial statements, assessment of current performance, and choice of comparable firms and prediction of future performance to perform the valuation.Starting at €8.20
-
Coca-Cola: Residual Income Valuation, Teaching Note
Srinivasan, Suraj; Riedl, Edward J.Teaching Note HBS-113065-EAccounting and ControlTeaching note for a case of the same title that introduces students to the residual income (also known as the abnormal earnings) valuation model using the firm Coca-Cola. Students are provided with the primary financial statements (through fiscal 2010) and forecast data/assumptions. These data are used as input into a simple spreadsheet model to derive pro-forma summary financial statements (balance sheet and income statement), as well as Coca-Co...Starting at €0.00
-
Adaptive Platform Trials: The Clinical Trial of the Future
Stern, Ariel D.; Mehta, SarahCase HBS-618025-EService and Operations ManagementIn July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial-an adaptive platform trial-to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. Alexander believed that the standard way in which new cancer drugs were tested-the traditional randomized controlled trial (RCT)-was limited in many ways. While statistically rigorous and s...Starting at €8.20
-
Twine Health, Teaching Note
Huckman, Robert S.; Stern, Ariel D.Teaching Note HBS-618055-EService and Operations ManagementTeaching note for case 615068.Starting at €0.00
-
Maven Clinic: Women's Health in the Digital Age
Stern, Ariel D.; Mehta, SarahCase HBS-620035-EStrategyIn late 2017, Kate Ryder, the founder and CEO of digital women's health telemedicine company Maven Clinic, faced an important decision. Maven offered both a direct to consumer (D2C) product that anyone could use to book virtual appointments with health practitioners across a range of services and specialties for a fee, and an enterprise product-the Maven Family Benefits platform-which it sold to large employers as an employee benefit. Since found...Starting at €8.20
-
Twine Health
Huckman, Robert S.; Stern, Ariel D.; Preble, MatthewCase HBS-615068-EService and Operations ManagementIn late 2014, Dr. John Moore (CEO), Frank Moss (chairman), and Scott Gilroy (CTO) of Twine Health (Twine) had to resolve several challenges that threatened to restrict the widespread dissemination of its sole product, Twine. Twine was a cloud-based platform that enabled patients to create and manage chronic disease treatment plans in conjunction with their primary care providers and specialized coaches. Twine had already enjoyed impressive succes...Starting at €8.20
-
Adaptive Platform Trials: The Clinical Trial of the Future, Teaching Note
Stern, Ariel D.; Mehta, SarahTeaching Note HBS-618048-EEntrepreneurshipThis teaching note provides guidance and recommendations for teaching HBS Case No. 618025, entitled "Adaptive Platform Trials: The Clinical Trial of the Future?"Starting at €0.00
-
Adaptive Platform Trials: The Clinical Trial of the Future (B)
Stern, Ariel D.; Mehta, SarahCase HBS-620001-EEntrepreneurshipThis case provides an update to the (A) case, which introduces students to adaptive platform trials, an ambitious, more efficient type of clinical trial that increases access to therapies. The A case centers on Dr. Brian Alexander's efforts to launch an adaptive platform trial for studying potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. The (B) case provides an update and explores the strategies that Alexander is c...Starting at €5.74